Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study.
Minoru FukudaMasafumi YamaguchiTakuya YamazakiSoichiro FunakiHiroshi MukaeJunya FukuokaKazuki NabeshimaHisashi TateyamaKazuto AshizawaNoriyuki TomiyamaMasaki HaraTakashi SetoMeinoshin OkumuraKenji SugioPublished in: Thoracic cancer (2022)
Although it was difficult to recruit patients, there was a long-term survivor >4 years who appeared to have achieved a CR, indicating that such chemoradiotherapy may be effective against locally advanced thymic carcinoma.